Integration of DCE-MRI and DW-MRI Quantitative Parameters for Breast Lesion Classification

Objective. The purpose of our study was to evaluate the diagnostic value of an imaging protocol combining dynamic contrast-enhanced MRI (DCE-MRI) and diffusion-weighted MRI (DW-MRI) in patients with suspicious breast lesions. Materials and Methods. A total of 31 breast lesions (15 malignant and 16 benign proved by histological examination) in 26 female patients were included in this study. For both DCE-MRI and DW-MRI model free and model based parameters were computed pixel by pixel on manually segmented ROIs. Statistical procedures included conventional linear analysis and more advanced techniques for classification of lesions in benign and malignant. Results. Our findings indicated no strong correlation between DCE-MRI and DW-MRI parameters. Results of classification analysis show that combining of DCE parameters or DW-MRI parameter, in comparison of single feature, does not yield a dramatic improvement of sensitivity and specificity of the two techniques alone. The best performance was obtained considering a full combination of all features. Moreover, the classification results combining all features are dominated by DCE-MRI features alone. Conclusion. The combination of DWI and DCE-MRI does not show a potential to dramatically increase the sensitivity and specificity of breast MRI. DCE-MRI alone gave the same performance as in combination with DW-MRI.

[1]  Jie Chen,et al.  Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer? , 2012, Breast Cancer Research and Treatment.

[2]  Han Wen,et al.  In vivo study of microcirculation in canine myocardium using the IVIM method † , 2003, Magnetic resonance in medicine.

[3]  S. Brockstedt,et al.  Perfusion-related parameters in intravoxel incoherent motion MR imaging compared with CBV and CBF measured by dynamic susceptibility-contrast MR technique , 2001, Acta radiologica.

[4]  A. Luciani,et al.  Liver Cirrhosis : Intravoxel Incoherent Motion MR Imaging — Pilot Study 1 , 2008 .

[5]  Mariko Goto,et al.  Diagnosis of breast tumors by contrast‐enhanced MR imaging: Comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features , 2007, Journal of magnetic resonance imaging : JMRI.

[6]  P. Grenier,et al.  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. , 1986, Radiology.

[7]  Sang Ho Lee,et al.  Texture analysis of lesion perfusion volumes in dynamic contrast-enhanced breast MRI , 2008, 2008 5th IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

[8]  S. Sourbron Technical aspects of MR perfusion. , 2010, European journal of radiology.

[9]  Gregory S Karczmar,et al.  Estimating the arterial input function using two reference tissues in dynamic contrast‐enhanced MRI studies: Fundamental concepts and simulations , 2004, Magnetic resonance in medicine.

[10]  Thomas E Yankeelov,et al.  Parameterizing the Logistic Model of Tumor Growth by DW-MRI and DCE-MRI Data to Predict Treatment Response and Changes in Breast Cancer Cellularity during Neoadjuvant Chemotherapy. , 2013, Translational oncology.

[11]  David J Collins,et al.  Dynamic magnetic resonance imaging of tumor perfusion. Approaches and biomedical challenges. , 2004, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.

[12]  M D Schnall,et al.  Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast. , 1997, AJR. American journal of roentgenology.

[13]  D. Le Bihan,et al.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. , 1988, Radiology.

[14]  Orhan Nalcioglu,et al.  Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer , 2003, Journal of magnetic resonance imaging : JMRI.

[15]  L R Schad,et al.  Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. , 1991, Journal of computer assisted tomography.

[16]  Yoshitsugu Matsumoto,et al.  In vitro experimental study of the relationship between the apparent diffusion coefficient and changes in cellularity and cell morphology. , 2009, Oncology reports.

[17]  T. Moteki,et al.  Evaluation of hepatic lesions and hepatic parenchyma using diffusion‐weighted echo‐planar MR with three values of gradient b‐factor , 2006, Journal of magnetic resonance imaging : JMRI.

[18]  James R. Schott,et al.  Principles of Multivariate Analysis: A User's Perspective , 2002 .

[19]  P. Tofts Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[20]  Tom Fawcett,et al.  ROC Graphs: Notes and Practical Considerations for Researchers , 2007 .

[21]  D. Collins,et al.  Dynamic magnetic resonance imaging of tumor perfusion , 2004, IEEE Engineering in Medicine and Biology Magazine.

[22]  Karel G M Moons,et al.  Meta-analysis of MR imaging in the diagnosis of breast lesions. , 2008, Radiology.

[23]  Wendy B DeMartini,et al.  Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. , 2009, AJR. American journal of roentgenology.

[24]  Mario Sansone,et al.  Dynamic contrast-enhanced MRI in breast cancer: A comparison between distributed and compartmental tracer kinetic models , 2012 .

[25]  M V Knopp,et al.  Dynamic contrast-enhanced magnetic resonance imaging in oncology. , 2001, Topics in magnetic resonance imaging : TMRI.

[26]  E A Sickles,et al.  Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. , 2000, AJR. American journal of roentgenology.

[27]  Gary P Liney,et al.  Correlation of ADC and T2 Measurements With Cell Density in Prostate Cancer at 3.0 Tesla , 2009, Investigative radiology.

[28]  Hongmin Cai,et al.  Diagnostic assessment by dynamic contrast-enhanced and diffusion-weighted magnetic resonance in differentiation of breast lesions under different imaging protocols , 2014, BMC Cancer.

[29]  M D Schnall,et al.  A combined architectural and kinetic interpretation model for breast MR images. , 2001, Academic radiology.

[30]  A Heinig,et al.  Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. , 1997, European journal of radiology.

[31]  Mario Sansone,et al.  Influence of Parameterization on Tracer Kinetic Modeling in DCE-MRI , 2014 .

[32]  C. Kuhl,et al.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? , 1999, Radiology.

[33]  N. Perkins,et al.  Optimal Cut-point and Its Corresponding Youden Index to Discriminate Individuals Using Pooled Blood Samples , 2005, Epidemiology.

[34]  Sibel Kul,et al.  Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. , 2011, AJR. American journal of roentgenology.

[35]  G. Brix,et al.  Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[36]  Li Li,et al.  Diagnosis of Breast Masses from Dynamic Contrast-Enhanced and Diffusion-Weighted MR: A Machine Learning Approach , 2014, PloS one.

[37]  U. Sinha,et al.  Imaging the microcirculatory proton fraction of muscle with diffusion-weighted echo-planar imaging. , 2000, Academic radiology.

[38]  Antonella Petrillo,et al.  An expectation-maximisation approach for simultaneous pixel classification and tracer kinetic modelling in dynamic contrast enhanced-magnetic resonance imaging , 2011, Medical & Biological Engineering & Computing.

[39]  H. Weinmann,et al.  Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.

[40]  Fiona J Gilbert,et al.  Reading protocol for dynamic contrast-enhanced MR images of the breast: sensitivity and specificity analysis. , 2005, Radiology.

[41]  J. Gore,et al.  Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. , 2005, Magnetic resonance imaging.

[42]  Axel Saalbach,et al.  Image fusion for dynamic contrast enhanced magnetic resonance imaging , 2004, Biomedical engineering online.

[43]  Wei Huang,et al.  Detection of breast malignancy: diagnostic MR protocol for improved specificity. , 2004, Radiology.

[44]  Marilyn M. Bui,et al.  Using image analysis as a tool for assessment of prognostic and predictive biomarkers for breast cancer: How reliable is it? , 2010, Journal of pathology informatics.

[45]  Glen R Morrell,et al.  Pharmacokinetic mapping for lesion classification in dynamic breast MRI , 2010, Journal of magnetic resonance imaging : JMRI.

[46]  Mario Sansone,et al.  Use of Tracer Kinetic Models for Selection of Semi-Quantitative Features for DCE-MRI Data Classification , 2013 .

[47]  M. Rinaldo,et al.  Can semi-quantitative evaluation of uncertain (type II) time-intensity curves improve diagnosis in breast DCE-MRI? , 2013 .

[48]  Wendy B DeMartini,et al.  In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters. , 2012, Radiology.

[49]  Jong Hyo Kim,et al.  Multilevel analysis of spatiotemporal association features for differentiation of tumor enhancement patterns in breast DCE-MRI. , 2010, Medical physics.